NACDS partners with public health agencies to expand hepatitis testing
NACDS evaluating how increased access to Hepatitis C and HIV testing increases patient screenings. Read More »
Genentech's Alecensa study in Japan reveals better results than crizotinib
Phase III study in Japan shows positive results in participants with advanced lung cancer. Read More »
Three states and DC join the prescription monitoring program
More than 40 states have joined NABP PMP InterConnect to reduce prescription drug abuse. Read More »
Walgreens announces launch of CF Champions Program
Online program supports cystic fibrosis patients, caregivers and others affected by the disease. Read More »
Health insurers seek closer link between drug prices and efficacy
Cigna Corp. may receive additional price discounts from pharmaceutical companies should new cholesterol medications prove less effective than expected — a move marks a crucial step in a broader initiative to link the cost of medications to their efficacy. Read More »
Decongestant access depends on pharmacist judgment in Indiana
A new law in Indiana gives pharmacists the freedom of judgment to determine whether to dispense decongestants in an effort to interrupt the supply chain that produces methamphetamines Read More »
Maine develops new approach for limiting opioid prescriptions
Maine Gov. Paul R. LePage recently signed into law a new state law that limits the doses, duration, and overall prescription of opioid therapies. Read More »
CVS Pharmacy opens store in New Orleans Lower Ninth Ward
CVS Pharmacy recently opened a location in New Orleans Lower Ninth Ward, making it the first major retailer to establish a location in that area since Hurricane Katrina. Read More »
May is Stroke Awareness Month
In recognition of May being Stroke Awareness Month, Prime Therapeutics LLC noted recently the importance medication plays in preventing strokes. Read More »
Merck and Pfizer to present avelumab data at ASCO annual meeting
Fourteen presentations will present results of avelumab treatments for seven different cancer types. Read More »
FDA approves new treatment for bladder cancer
Targeted treatment with Tecentriq approved; it is the first PD-L1 inhibitor approved by FDA for urothelial carcinoma. Read More »
Pfizer to present more than 40 abstracts at ASCO annual meeting
Pfizer will showcase its growing portfolio of innovative treatments for a variety of cancers. Read More »
CVS releases 2015 Corporate Social Responsibility Report
Updates on CVS Health's goals and initiatives for 2015 presented. Read More »
Pfizer survey finds disconnect between RA patients and doctors
Communication key to developing treatment goals and disease management plan. Read More »
Allergan announces poster presentations at ASH Annual Scientific Meeting
Four posters on nebivolol and fixed-dose combination of nebivolol and valsartan were presented. Read More »
Aetna announces collaboration with Providence in Los Angeles
Aetna customers to receive coordinated care from Providence hospitals and health care providers. Read More »
NACDS video ad urges pharmacy professionals to participate in the political process
Second video spot debuts; urges pharmacy personnel to volunteer and vote for their preferred candidates. Read More »
ASHP announces Informatics Certificate Program
New certificate program added to ASHP online continuing education program for pharmacists and pharmacy technicians. Read More »
McKesson and TriZetto collaborate to improve claims payment accuracy
McKesson's ClaimsXten and ClaimsXten Select will integrate with TriZetto's QNXT to simplify claims management. Read More »
Positive results announced for Allergan trials of Oculeve Intranasal Tear Neurostimulator
Two clinical trials show tear production increased in patients suffering from dry eye disease. Read More »
Alerts Sign-up